BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28484252)

  • 21. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
    Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
    Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
    Huang Y; Du Q; Wu W; She F; Chen Y
    Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
    Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM
    J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence.
    Ramachandran I; Ganapathy V; Gillies E; Fonseca I; Sureban SM; Houchen CW; Reis A; Queimado L
    Cell Death Dis; 2014 May; 5(5):e1246. PubMed ID: 24853424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.
    Shen Z; Chen C; Sun J; Huang J; Liu S
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2239-2248. PubMed ID: 34037837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WIF1 was downregulated in cervical cancer due to promoter methylation.
    Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
    Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.
    Liu K; Zhang Y; Zhang C; Zhang Q; Li J; Xiao F; Li Y; Zhang R; Dou D; Liang J; Qin J; Lin Z; Zhao D; Jiang M; Liang Z; Su J; Gupta VP; He M; Yang X
    Oncotarget; 2016 Aug; 7(35):56798-56810. PubMed ID: 27462864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.
    Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y
    Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
    Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
    Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
    Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
    Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.
    Baker EK; Taylor S; Gupte A; Chalk AM; Bhattacharya S; Green AC; Martin TJ; Strbenac D; Robinson MD; Purton LE; Walkley CR
    Bone; 2015 Apr; 73():223-32. PubMed ID: 25571841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genistein inhibits invasion and migration of colon cancer cells by recovering WIF1 expression.
    Zhu J; Ren J; Tang L
    Mol Med Rep; 2018 May; 17(5):7265-7273. PubMed ID: 29568950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
    Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.
    Michaelsen SR; Aslan D; Urup T; Poulsen HS; Grønbæk K; Broholm H; Kristensen LS
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberration of
    Liu P; Garbutt C; Hornicek FJ; Liu F; Duan Z
    Anticancer Res; 2017 Jun; 37(6):2939-2945. PubMed ID: 28551631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
    Dai W; Teodoridis JM; Zeller C; Graham J; Hersey J; Flanagan JM; Stronach E; Millan DW; Siddiqui N; Paul J; Brown R
    Clin Cancer Res; 2011 Jun; 17(12):4052-62. PubMed ID: 21459799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.